19 November 2015

Queensland researchers have identified genetic variations they hope will make it easier to assess whether patients have an aggressive form of prostate cancer.

Queensland University of Technology Professor Judith Clements said the variations affected the level of prostate-specific antigens (PSA), a protein produced by the prostate gland cells.

Increased levels indicate the likely presence of prostate cancer.

Read the full article on Financial Review.